Back
Range Cancer Therapeutics ETF Vs. Pilgrims Pride Industry Stock Comparison
Sell
41
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.72
Seasonality Move:
-0.36%
Buy
53
PPC
Pilgrims Pride
Last Price:
44.62
Seasonality Move:
0.35%
Sell
41
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.95. The Score for CNCR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Pilgrims Pride (PPC)
is a Buy
Is Pilgrims Pride a Buy, Sell or Hold?
- The current Pilgrims Pride [PPC] share price is $44.60. The Score for PPC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PPC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PPC Stock Price Chart
What is Pilgrims Pride's stock price today?
-
The Pilgrims Pride share price today is $44.60
The current trend is moderately bullish and PPC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.45 | Sell |
| Chaikin Money Flow: | 2676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.61 - 15.55) | Sell |
| Bollinger Bands (100): | (13.96 - 15.32) | Buy |
PPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 52.2 | Buy |
| Chaikin Money Flow: | 1509686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.77 - 45.97) | Buy |
| Bollinger Bands (100): | (36.75 - 44.25) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.85 | Buy |
| 20-day SMA: | 15.22 | Sell |
| 50-day SMA: | 14.81 | Buy |
| 200-day SMA: | 14.9 | Buy |
| 8-day EMA: | 14.89 | Buy |
| 20-day EMA: | 15 | Sell |
| 50-day EMA: | 14.89 | Buy |
| 200-day EMA: | 14.49 | Buy |
PPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.99 | Sell |
| 20-day SMA: | 43.38 | Buy |
| 50-day SMA: | 43.79 | Buy |
| 200-day SMA: | 36.03 | Buy |
| 8-day EMA: | 44.89 | Sell |
| 20-day EMA: | 44.2 | Buy |
| 50-day EMA: | 43.09 | Buy |
| 200-day EMA: | 37.07 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pilgrims Pride Earnings Growth & PPC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.02 per share, and a decrease next year of $0.66 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pilgrims Pride Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||